Zenas BioPharma (ZBIO) Treasury Shares (2023 - 2026)

Zenas BioPharma's Treasury Shares history runs 4 years deep, the most recent figure standing at $667600.0 for Q1 2026.

• On a quarterly basis, Treasury Shares changed N/A year-over-year to $667600.0 in Q1 2026; TTM through Mar 2026 was $667600.0, a N/A change from a year earlier, with the FY2025 full-year figure at $599675.0, changed N/A from the prior year.
• Treasury Shares climbed to $667600.0 in Q1 2026 per ZBIO's latest filing, from $599675.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $116.3 million in Q2 2024 and bottomed at $511100.0 in Q2 2025.
• The 4-year median for Treasury Shares is $9.1 million (2023), against an average of $37.3 million.
• Biggest YoY gain for Treasury Shares was 99.56% in 2025; the steepest drop was 99.56% in 2025.
• Year by year, Treasury Shares stood at $17.6 million in 2023, then jumped by 561.05% to $116.3 million in 2024, then slumped by 99.48% to $599675.0 in 2025, then gained by 11.33% to $667600.0 in 2026.
• Per Business Quant, the three latest ZBIO Treasury Shares figures stand at $667600.0 (Q1 2026), $599675.0 (Q4 2025), and $525350.0 (Q3 2025).